VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U5581CA: VAERS reports

29 VAERS reports list lot U5581CA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2017-02-03 and 2017-11-02. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
29
Reports
21%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3641%
Musculoskeletal1112%
Neurological89%
Dermatological (non-injection-site)89%
General / Systemic (non-local)89%
Allergic / Anaphylactic78%
Cardiac / Cardiovascular45%
Gastrointestinal33%
Respiratory22%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Massachusetts3
California3
New York3
North Carolina2
Missouri2
Ohio2
Oklahoma2
Texas2
Michigan1
Nebraska1
Iowa1
South Carolina1

Reports by month received

2017-022
2017-032
2017-044
2017-052
2017-064
2017-075
2017-082
2017-095
2017-102
2017-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.